biotech
Ovarian cancer rates set to rise by 55%
May 1, 2018Manufacturing and Production, Medical Communications biotech, drugs, ovarian cancer, pharma, pharmaceutical
Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type …
Novartis reveals more data for Eylea rival
May 1, 2018Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical
Building on the back of strong data released at the end of last year, Novartis has released further positive Phase …
Lilly hires new leader of immuno-oncology
May 1, 2018Manufacturing and Production, Medical Communications Eli Lilly, biotech, drugs, immunoconlogy, immunotherapy, pharma, pharmaceutical
Immuno-oncology has become a huge area of the oncology market, led by the wave of PD-1/L1 drugs that are reaping …
Connecting patients to doctors
April 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …
Alzheon shies away from $81m IPO
April 30, 2018Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical
Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …
US applies pressure on Canada to stem cross-border generics flow
April 30, 2018Sales and Marketing Canada, IP, US, biotech, drugs, pharma, pharmaceutical
The US has upped the ante against Canada to secure stronger border checks for pharmaceutical goods by adding the country …
Health to hand
April 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Breast Cancer Care, biotech, drugs, pharma, pharmaceutical
Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …
House of Lords unloads both barrels on Government’s life science strategy approach
April 26, 2018Medical Communications ABPI, Life Sciences Industrial Strategy, UK government, biotech, drugs, pharma, pharmaceutical
The Life Sciences Industrial Strategy was supposed to forge a path forward for the industry, despite pressures from Brexit, to …
Takeda announce new UK MD, ahead of possible Shire transformation
April 26, 2018Medical Communications Shire, Takeda, biotech, drugs, pharma, pharmaceutical
“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
Common antidepressants linked to dementia risk
April 26, 2018Medical Communications anticholinergic, biotech, dementia, drugs, pharma, pharmaceutical
A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …
Novartis forges forward into digital pharma with FocalView app
April 25, 2018Medical Communications, Research and Development FocalView, Novartis, biotech, drugs, pharma, pharmaceutical
There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …
Sanofi makes ex-Roche scientist new R&D chief
April 25, 2018Medical Communications, Research and Development Roche, Sanofi, biotech, drugs, pharma, pharmaceutical
With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …
$64bn Takeda-Shire mega merger inches closer to closing
April 25, 2018Research and Development, Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …
Lilly’s arthritis drug hits trouble at FDA committee
April 24, 2018Manufacturing and Production, Sales and Marketing Eli Lilly, Incyte, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis
FDA’s advisory committee were openly conflicted about deciding on the safety of Eli Lilly and Incyte’s drug, baricitinib, for the …
AZ’s combo woes continue, with failure in lung cancer
April 24, 2018Manufacturing and Production, Research and Development AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical
AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it …
Latest content
